SHORTCUTS

May 2014   Psychooncology. 2014 May;23(5):481-92 Physical and psychosocial problems in cancer survivors beyond return to work: a systematic review Duijts SF, van Egmond MP, Spelten E, van Muijen P, Anema JR, van der Beek AJ This systematic review of employed cancer survivors screened nearly 9000 articles, with 30 studies (20 quantitative and 10 qualitative) […]

Read More…

SHORTCUTS

May 2014   J Clin Oncol. 2014 Apr 14. [Epub ahead of print] Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline Hershman DL, Lacchetti C, Dworkin RH, Lavoie Smith EM, Bleeker J, Cavaletti G, Chauhan C, Gavin P, Lavino A, Lustberg MB, Paice […]

Read More…

SHORTCUTS

May 2014   BMJ 2014 March. [Epub ahead of print] Associations between palliative chemotherapy and adult cancer patients’ end of life care and place of death: prospective cohort study Alexi A Wright, Baohui Zhang, Nancy L Keating, Jane C Weeks, Holly G Prigerson This study investigated the relationship between chemotherapy in patients with metastatic cancer […]

Read More…

SHORTCUTS

May 2014   Cancer J. 2014 Jan-Feb;20(1):8-14 A Randomized, Double-blind, 2-Period, Placebo-Controlled Crossover Trial of a Sustained-Release Methylphenidate in the Treatment of Fatigue in Cancer Patients Escalante CP, Meyers C, Reuben JM, Wang X, Qiao W, Manzullo E, Alvarez RH, Morrow PK,Gonzalez-Angulo AM, Wang XS, Mendoza T, Liu W, Holmes H, Hwang J, Pisters K, […]

Read More…

News and updates from www.palliativedrugs.com

2nd May 2014 Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website.   Safety updates EMA restricts domperidone dose and duration of use The European Medicines Agency (EMA) has recommended changes to the indications, dose and duration of use of domperidone in adults and children following a […]

Read More…

SHORTCUTS

May 2014   J Anal Toxicol. 2013 Oct;37(8):476-85 In vitro inhibition of methadone and oxycodone cytochrome P450-dependent metabolism: reversible inhibition by H2-receptor agonists and proton-pump inhibitors Moody DE, Liu F, Fang WB The effect of Histamine 2 (H2)-receptor antagonists and proton-pump inhibitors (PPIs) on the metabolism of oxycodone and methadone was evaluated in an in vitro […]

Read More…

E-Letter Response to ‘Comparing the needs of families of children dying from malignant and non- malignant disease: an in-depth qualitative study’ (Jayne Price, Joanne Jordan, Lindsay Prior, Jackie Parkes, BMJ Supportive and Palliative Care (2012; 2: 127-132))

Article citation: Jayne Price, Joanne Jordan, Lindsay Prior, Jackie Parkes; ‘Comparing the needs of families of children dying from malignant and non-malignant disease: an in-depth qualitative study’; BMJ Supportive and Palliative Care (2012; 2: 127-132) Abstract, Full Text, PDF   Our journal club appraised with interest the study of Jayne Price and colleagues, which compared the needs […]

Read More…

E-Letter Response: ‘Don’t be Bitter: be Better’

Article Citation: Catherine Sweeney, Gerardine Lynch, Ali Khashan, Bridget Maher, Marie Murphy, Tony O’Brien; ‘The impact of a medical undergraduate student-selected module in palliative care’; BMJ Supportive and  Palliative Care (2014; 4: 92-97) Abstract, Full Text, PDF   Death is arguably the most important thing about us. It is our ‘condition of creation’ so to speak, and to deny its […]

Read More…

News and updates from www.palliativedrugs.com

Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website.   Hot topics Tramadol to be a Schedule 3 CD and temazepam exemptions to be removed The UK government has decided that tramadol will become a Schedule 3 controlled drug (CD) later this year, but will have exemption from […]

Read More…